Search Results 1251-1260 of 1755 for Reality Virtual

  1. A Trial to Evaluate the Efficacy and Safety of MOR208 With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    MOR00208 is an investigational drug. RTX and BEN are both approved in many countries for the treatment of lymphomas. The combination of both is considered and ...

  2. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    This study will also evaluate other anti-tumor effects, tumor markers and pharmacokinetics (PK) of zolbetuximab, Nab-P and GEM. Participation eligibility.

  3. Cenobamate Open-Label Extension Study for YKP3089C025 - Mayo Clinic

    The purpose of this study is to evaluate the long-term safety and tolerability of cenobamate adjunctive therapy in subjects with primary generalized tonic- ...

  4. Radiation Sickness Clinical Trials - Mayo Clinic Research

    Establish a registry of patient data and germline DNA samples for validation of models and biomarkers for early detection of risk of radiotherapy related side ...

  5. Remote patient monitoring provides patients with comprehensive care at home - Mayo Clinic News Network

    See how we're providing safe in-person care and virtual visits · Review the latest COVID-19 resources and research advancements. Information in this post was ...

  6. Integrating telemedicine into the Mayo Clinic Urology practice to expand options for patients

    The COVID-19 pandemic provided opportunities to explore telemedicine consults with adult and pediatric urology patients.

  7. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. By eliminating bias in AI models and offering access to deidentified data, Mayo Clinic Platform aims to transform health care

    "We feel Mayo Clinic Platform is uniquely positioned to make this ambitious goal a reality because we are founded on Mayo Clinic's dedication to patient- ...

  9. Diversity Science - Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery - Mayo Clinic Research

    The Diversity Science Program in the Mayo Clinic Kern Center for the Science of Health Care Delivery advances inclusive, equitable norms for organizational ...

  10. Chronic Intestinal Pseudo Obstruction de novo Clinical Outcomes Assessment

    About this study. The purpose of this study is to develop a de novo CIPO-specific PRO that is able to capture change in core CIPO visible signs and symptoms ...